Anthony D. Wright
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anthony D. Wright has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Gabriele Maria König
Institute of Pharmaceutical Biology, University of Bonn, Nussallee 6, 53115 Bonn, Germany
2 shared publications Olaf Papendorf
2 shared publications- Axel Oberemm
Federal Institute for Risk Assessment, Berlin, Germany
1 shared publication Cindy K. Angerhofer
Australian Institute of Marine Science, PMB No. 3, Townsville MC, Qld 4810, Australia, School of Marine Biology and Aquaculture, James Cook University, Townsville, Qld 4811, Australia, Aveda Corporation, Minneapolis, Minnesota 55449, College of Pharmacy, Nursing, and Health Sciences, Purdue University, West Lafayette, Indiana 47907, and Institute for Pharmaceutical Chemistry, Heinrich-Heine University, Universitätsstrasse 1, D-40225 Düsseldorf, Germany
1 shared publicationJohn M. Pezzuto
Australian Institute of Marine Science, PMB No. 3, Townsville MC, Qld 4810, Australia, School of Marine Biology and Aquaculture, James Cook University, Townsville, Qld 4811, Australia, Aveda Corporation, Minneapolis, Minnesota 55449, College of Pharmacy, Nursing, and Health Sciences, Purdue University, West Lafayette, Indiana 47907, and Institute for Pharmaceutical Chemistry, Heinrich-Heine University, Universitätsstrasse 1, D-40225 Düsseldorf, Germany
1 shared publicationMarion Gurrath
Australian Institute of Marine Science, PMB No. 3, Townsville MC, Qld 4810, Australia, School of Marine Biology and Aquaculture, James Cook University, Townsville, Qld 4811, Australia, Aveda Corporation, Minneapolis, Minnesota 55449, College of Pharmacy, Nursing, and Health Sciences, Purdue University, West Lafayette, Indiana 47907, and Institute for Pharmaceutical Chemistry, Heinrich-Heine University, Universitätsstrasse 1, D-40225 Düsseldorf, Germany
1 shared publication
Latest Publications
- 1 October 2006
- Published by Elsevier in Chemosphere
- Vol. 65 (4) , 604-608
Effects of cyanobacterium Fischerella ambigua isolates and cell free culture media on zebrafish (Danio rerio) embryo development
- 1 October 2006
- Published by Elsevier in Chemosphere
- Vol. 65 (4) , 604-608
Effects of cyanobacterium Fischerella ambigua isolates and cell free culture media on zebrafish (Danio rerio) embryo development
- 1 August 2006
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 69 (8) , 1180-1187
Biological Activities and 3D QSAR Studies of a Series of Delisea pulchra (cf. fimbriata) Derived Natural Products
Twenty-five natural products, mainly halogenated furanones, isolated from the temperate red algae Delisea pulchra were investigated for their cytotoxic, antimicrobial, and antiplasmodial effects, their inhibition of the activity of the enzymes HIV-1-RT (HIV-1-reverse transcriptase), PKC (protein kinase C), and TK (tyrosine kinase), and their inhibition of the biosynthesis of IL-1 (interleukin-1). All were found to mediate a positive response in one or more of these test systems. In particular, compounds 9, 11, 12, 14, 16, 17, 19, and 20 demonstrated cytotoxic activity in all of the assays they were tested in; compounds 11, 12, 17, 19, and 20 were also active in the majority of the anti-infective screens. In the antimalarial and tyrosine kinase assays, compounds 17, 19, and 20 were all active. Molecular modeling studies employing 3D QSAR with receptor modeling methodologies performed with 16 halogenated furanones generated a pharmacophore hypothesis consistent with the experimentally derived cytotoxicity data. This hypothesis is developed around an active molecule having a framework based on compound 11 with an OH function or OAc (assay dependent) at C-7 and bulky electron-rich groups at C-6, such as Cl and Br but not I.
- 1 August 2006
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 69 (8) , 1180-1187
Biological Activities and 3D QSAR Studies of a Series of Delisea pulchra (cf. fimbriata) Derived Natural Products
Twenty-five natural products, mainly halogenated furanones, isolated from the temperate red algae Delisea pulchra were investigated for their cytotoxic, antimicrobial, and antiplasmodial effects, their inhibition of the activity of the enzymes HIV-1-RT (HIV-1-reverse transcriptase), PKC (protein kinase C), and TK (tyrosine kinase), and their inhibition of the biosynthesis of IL-1 (interleukin-1). All were found to mediate a positive response in one or more of these test systems. In particular, compounds 9, 11, 12, 14, 16, 17, 19, and 20 demonstrated cytotoxic activity in all of the assays they were tested in; compounds 11, 12, 17, 19, and 20 were also active in the majority of the anti-infective screens. In the antimalarial and tyrosine kinase assays, compounds 17, 19, and 20 were all active. Molecular modeling studies employing 3D QSAR with receptor modeling methodologies performed with 16 halogenated furanones generated a pharmacophore hypothesis consistent with the experimentally derived cytotoxicity data. This hypothesis is developed around an active molecule having a framework based on compound 11 with an OH function or OAc (assay dependent) at C-7 and bulky electron-rich groups at C-6, such as Cl and Br but not I.
- 20 July 2005
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 71 (10) , 964-966
Potential Antimalarial Lead Structures from Fungi of Marine Origin
Antiplasmodial and cytotoxicity testing of five highly oxygenated natural products (6R,12R,14R-colletoketol, 6R,11R,12R,14R-colletoketodiol, dihydrobotrydial, pycnidione, and 3R,4S-hydroxymellein), all derived from fungi of marine origin, showed one of them, pycnidione, to have activities against three different strains of Plasmodium falciparum in the sub-micromolar (μM) range. Although the mean selectivity index of 1 for the observed antiplasmodial activity of 4 is low, pycnidione’s usefulness as a potential lead structure should not be ignored.
- 20 July 2005
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 71 (10) , 964-966
Potential Antimalarial Lead Structures from Fungi of Marine Origin
Antiplasmodial and cytotoxicity testing of five highly oxygenated natural products (6R,12R,14R-colletoketol, 6R,11R,12R,14R-colletoketodiol, dihydrobotrydial, pycnidione, and 3R,4S-hydroxymellein), all derived from fungi of marine origin, showed one of them, pycnidione, to have activities against three different strains of Plasmodium falciparum in the sub-micromolar (μM) range. Although the mean selectivity index of 1 for the observed antiplasmodial activity of 4 is low, pycnidione’s usefulness as a potential lead structure should not be ignored.
- 1 March 2005
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 68 (3) , 459-461
Ambigol C and 2,4-Dichlorobenzoic Acid, Natural Products Produced by the Terrestrial Cyanobacterium Fischerella ambigua
The new natural products 3,5-bis(2,4-dichlorophenoxy)-2,6-dichlorophenol (ambigol C, 1), a highly chlorinated aromatic compound, and 2,4-dichlorobenzoic acid (2) were isolated from the terrestrial cyanobacterium Fischerella ambigua together with the known compounds ambigol A (3) and tjipanazole D (4). All structures were secured by extensive spectroscopic analysis (1D and 2D NMR, MS, UV, IR). Ambigol C has moderate activity against Trypanosoma rhodesiense.
- 1 March 2005
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 68 (3) , 459-461
Ambigol C and 2,4-Dichlorobenzoic Acid, Natural Products Produced by the Terrestrial Cyanobacterium Fischerella ambigua
The new natural products 3,5-bis(2,4-dichlorophenoxy)-2,6-dichlorophenol (ambigol C, 1), a highly chlorinated aromatic compound, and 2,4-dichlorobenzoic acid (2) were isolated from the terrestrial cyanobacterium Fischerella ambigua together with the known compounds ambigol A (3) and tjipanazole D (4). All structures were secured by extensive spectroscopic analysis (1D and 2D NMR, MS, UV, IR). Ambigol C has moderate activity against Trypanosoma rhodesiense.